News & Perspective

Feb 08, 2008

Feb 08, 2008

US military switching to new smallpox vaccine

Editor's note: This story was revised Feb 11 to include some additional information provided by the Department of Defense.

(CIDRAP News) – After vaccinating more than a million personnel with the old-fashioned type of smallpox vaccine grown on the skin of calves, the US military is about to switch to a second-generation vaccine that's grown in laboratory cell cultures.

Sep 04, 2007

Sep 04, 2007

FDA approves Acambis smallpox vaccine

(CIDRAP News) – A second-generation smallpox vaccine made by the British biotechnology company Acambis plc and stockpiled by the US government as protection against bioterrorist attacks has been approved by the US Food and Drug Administration (FDA).

Oct 20, 2005

Oct 20, 2005

US funds tularemia vaccine research, secure labs

(CIDRAP News) – The US government has issued about $60 million in contracts to spur development of a vaccine against tularemia, the National Institutes of Health (NIH) announced recently.

The National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH, has issued two 5-year contracts for vaccine work, the agency said earlier this month. The agency also awarded $87 million in grants to build four biosafety level 3 (BSL-3) labs.

Mar 25, 2002

Mar 25, 2002

In simulated smallpox attack, vaccine shortage crippled national response

(CIDRAP News) – It is 13 days since the emergence of a hypothetical smallpox epidemic caused by the release of virus in three US shopping malls. Some 16,000 cases have been reported, 1,000 people have died, and the nation is running out of vaccine. Hospitals are overflowing, and federal and state officials are at odds over how to contain the epidemic.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»